ArticleMedicine2017

Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study.

Kuang-Tso Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.